Documents Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal....

Slide 1 Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal Molecular Subtype of Ovarian Cancer Presented By Boris Winterhoff…

Documents Presented By Boris Winterhoff at 2014 ASCO Annual Meeting

Slide 1 Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal Molecular Subtype of Ovarian Cancer Presented By Boris Winterhoff…